AJP - Cell Physiology, Vol 271, Issue 1 C54-C60, Copyright © 1996 by American Physiological Society

ARTICLES

Plasmin-platelet interaction involves cleavage of functional thrombin receptor

M. Kimura, T. T. Andersen, J. W. Fenton 2nd, W. F. Bahou and A. Aviv
Hypertension Research Center, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark 07103-2714, USA.

We tested the hypothesis that the inhibition of thrombin-induced platelet activation by plasmin is mediated via the enzymatic action of plasmin on the functional thrombin receptor. We monitored the binding of the anti-thrombin receptor antibody [anti-TR-(34-46)] to platelets; this binding is sensitive to the cleavage of the thrombin receptor at amino acid residues Arg-41 to Ser-42. Plasmin inhibited anti-TR-(34-46) binding in dose- and time-dependent manners. The inactive synthetic peptide with the amino acid sequence 40-55 of the thrombin receptor (D-FPRSFLLRNPNDKYEPF) was similarly cleaved by thrombin and plasmin to an active peptide (SFLLRNPNDKYEPF) that produced robust cytosolic Ca2+ responses. At high concentrations, plasmin itself can activate platelets. We explored this effect with the use of anti-TR-(1-160). This antibody abolished the cytosolic Ca2+ responses to thrombin and to the thrombin receptor-activating peptide SFLLRN but did not attenuate the plasmin-induced cytosolic Ca2+ response. Thus plasmin inhibits thrombin-evoked platelet activation by cleaving the thrombin receptor, but the plasmin-induced cytosolic Ca2+ response is not due to the generation of the tethered peptide of the thrombin receptor.

This article has been cited by other articles:

				U. R. Pendurthi, M. Ngyuen, P. Andrade-Gordon, L. C. Petersen, and L. V. M. Rao Plasmin Induces Cyr61 Gene Expression in Fibroblasts Via Protease-Activated Receptor-1 and p44/42 Mitogen-Activated Protein Kinase-Dependent Signaling Pathway Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1421 - 1426. [Abstract] [Full Text] [PDF]

				M. D. Hollenberg and S. J. Compton International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2002; 54(2): 203 - 217. [Abstract] [Full Text] [PDF]

				J. P. McRedmond, P. Harriott, B. Walker, and D. J. Fitzgerald Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1 Blood, February 15, 2000; 95(4): 1301 - 1308. [Abstract] [Full Text] [PDF]

				C. H. Gelband, J. D. Warth, H. S. Mason, M. Zhu, J. M. Moore, J. L. Kenyon, B. Horowitz, and C. Sumners Angiotensin II Type 1 Receptor–Mediated Inhibition of K+ Channel Subunit Kv2.2 in Brain Stem and Hypothalamic Neurons Circ. Res., February 19, 1999; 84(3): 352 - 359. [Abstract] [Full Text] [PDF]

				B. E. Figueroa, R. F. Keep, A. L. Betz, J. T. Hoff, and J. H. Garcia Plasminogen Activators Potentiate Thrombin-Induced Brain Injury • Editorial Comment Stroke, June 1, 1998; 29(6): 1202 - 1208. [Abstract] [Full Text] [PDF]

				M. Molino, M. J. Woolkalis, J. Reavey-Cantwell, D. Pratico, P. Andrade-Gordon, E. S. Barnathan, and L. F. Brass Endothelial Cell Thrombin Receptors and PAR-2. TWO PROTEASE-ACTIVATED RECEPTORS LOCATED IN A SINGLE CELLULAR ENVIRONMENT J. Biol. Chem., April 25, 1997; 272(17): 11133 - 11141. [Abstract] [Full Text] [PDF]

				M. Molino, E. S. Barnathan, R. Numerof, J. Clark, M. Dreyer, A. Cumashi, J. A. Hoxie, N. Schechter, M. Woolkalis, and L. F. Brass Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2 J. Biol. Chem., February 14, 1997; 272(7): 4043 - 4049. [Abstract] [Full Text] [PDF]